Brain Tumor Device By Duke Engineer Gains FDA Breakthrough Status | wfmynews2.com
Frontiers | Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of Glioblastoma | Oncology
Polio Injection Shrinks Woman's Brain Tumor - ABC News
Glioblastoma: New tools against brain cancer - CBS News
Poliovirus shows promise as a new weapon in the war against brain cancer - CNET
Clinical Trial Studies Treating Brain Tumor with Genetically Modified Poliovirus | University Hospitals
Poliovirus Therapy for Glioblastoma has Three-Year Survival Rate of 21 Percent | Duke Today
How the polio virus is being used to combat brain cancer | CNN
Duke Team Finds Missing Immune Cells That Could Fight Lethal Brain Tumors - Drug Discovery and Development
Poliovirus treatment for glioblastoma posts 'encouraging' survival data, but work remains | FierceBiotech
Glioblastoma and Other Primary Brain Cancers | Glioblastoma, Brain Cancer | Duke Health
Brain immunology and immunotherapy in brain tumours | Nature Reviews Cancer
Tumor Profiling and Targeted Treatment | Duke CAGPM
Researchers May Have Discovered a New Way to Kill off Cancer Cells
York doctor in Duke clinical trials for his own brain cancer
Clinical Trials | Clinical Trials | Lumicell
Cancer breakthrough: Duke clinical trial destroys SC woman's brain tumor
60 Minutes Updates Viewers on Poliovirus Therapy for Glioblastoma | Duke Health
Duke Cancer Institute Research Brain Cancer Cures-Promise but Questions Linger
The EndBrainCancer Initiative to Feature Renowned Brain Cancer and Modified Poliovirus Duke Researcher, Dr. Annick Desjardins, as its Keynote Speaker for the 2019 Annual May "Brains Matter" ACTION Dinner as Advocacy is
Duke University School of Medicine - Wikipedia
glioblastoma | Duke Cancer Institute
The EndBrainCancer Initiative to Feature Renowned Brain Cancer and Modified Poliovirus Duke Researcher, Dr. Annick Desjardins, as its Keynote Speaker for the 2019 Annual May "Brains Matter" ACTION Dinner as Advocacy is
Brain Tumor Microenvironment and Host State: Implications for Immunotherapy | Clinical Cancer Research
Trial tests treatment for John McCain's type of cancer | MUSC Research
